TEDCO’S LIFE SCIENCE INVESTMENT FUND INVESTS IN FOUR MARYLAND COMPANIES

July 22, 2016

 

COLUMBIA, MD (7/20/16) — The Maryland Technology Development Corporation (TEDCO) announced today that four Maryland companies received a total of $800,000 in funding through its Life Science Investment Fund (LSIF).

 

 

They are:

  • AsclepiX Therapeutics, a biotech company established to leverage the anti-angiogenic peptide development and the nano/microparticle technologies;

  • Sonavex, which has developed the EchoSure/EchoMark system to detect clots during surgeries, earlier and more reliably than existing modalities;

  • Vasoptic Medical, Inc., which leverages laser-based vascular imaging technology to solve diabetic retinopathy, deploying a portable blood flow monitor for early detection and management; and

  • Gel-e, which is focused on expanding its core technology platform to develop and commercialize hemostatic medical devices.

 

For full story click here.

Share on Facebook
Share on Twitter
Please reload

Recent News

Vasoptic Medical impresses at ARVO 2017

May 15, 2017

Vasoptic Medical's $1.5 million cash infusion pushes it toward FDA approval

April 25, 2017

Early Detection: New Device Measures Risk of Blindness from Diabetes

October 7, 2016

1/10
Please reload

© 2020 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230